World Health Organization (WHO). Global Strategy for Dengue Prevention and Control, 2012–2020; WHO: Geneva, Switzerland, 2012.
Benmansour, F.; Eydoux, C.; Querat, G. Novel 2-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,3,4-oxadiazole and 3-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,2,4-oxadiazole derivatives as dengue virus inhibitors targeting NS5 polymerase. Eur. J. Med. Chem., 2016, 109, 146-56.